Shruti Bhat PhD, MBA, Lean Six Sigma Black Belt
  • Home
  • About Shruti
  • Consulting
  • Workshops
  • Patents
  • Articles
    • Case Studies
    • Innovation Portfolio Development & Patents
    • Drugs-in-the- making
    • Culture Change & Business Transformation
    • Operational Excellence, Quality & Continuous Improvement
  • Books
  • Digital
  • Blog
  • Videos
  • Contact

USFDA Guidance on Life Sciences Regulatory Information Management

10/4/2022

0 Comments

 
USFDA guidance on life sciences regulatory information management
The USFDA recently released guidance to improve life sciences regulatory information management. The guidance aims to improve data input into the quality system and reduce low priority changes and should improve operational efficiency and regulatory flexibility. The guidance also requires that industry implement the appropriate regulatory framework and apply widely accepted risk management principles.
 
Data integrity
 
The USFDA has issued guidance for life sciences companies to improve data integrity. The guidance lays out the steps pharmaceutical firms must take to identify and manage data integrity risks and mitigate them. This includes implementing robust systems and effective data integrity controls. The guidance is intended to help pharmaceutical companies improve patient safety by reducing data integrity risks.
 
The guidance emphasizes the need for manufacturers to include cybersecurity information in their premarket submissions. It also specifies what kind of cybersecurity information should be included in those submissions.
 
Computer system assurance
 
The USFDA has issued a guidance that will improve computer system validation for the life sciences industry. This guidance will simplify the testing process while emphasizing critical thinking, risk management, and patient safety. Not only will it reduce the amount of documentation and cost, it will also make software systems more effective, allowing for faster time to market.
 
Computer system assurance is an essential part of a pharmaceutical organization's compliance program. The process involves testing a computer system to ensure that it meets regulatory requirements and is functional. It also includes testing it after it has undergone updates. It is not optional for companies, however, as the quality of their software systems could impact their approval by the FDA. By the way, I’ve a separate post touching upon transition from CSV to CSA. You may check it out here.
 
Data access to regulatory information
 
The Regulatory Information Management (RIM) process helps life sciences companies manage and control the processes involved in bringing new products to market, maintaining existing products on the market, and interacting with government regulators.
 
The regulatory process is becoming increasingly complex and demanding, and RIM is a key element of this process. As this process becomes more complex, the need for transparency increases as well. The future of RIM will likely include more digitally accessible data, allowing companies to better manage their registrations and comply with the regulations that govern them.
 
Data access is vital to life sciences regulatory information management, as the volume of information generated by the life sciences industry continues to grow exponentially. As a result, this sector must embrace new data analytics technologies to streamline the process and improve data quality. By leveraging data, RIM teams will be able to focus on higher-level strategic projects, rather than manually reviewing and analyzing information.
 
Integrated RIM solutions
 
The regulatory landscape for the life sciences industry is increasingly complex and evolving. To stay on top of the regulations and comply with the latest guidance, life sciences companies are turning to a new generation of RIMS solutions. A holistic RIM platform provides a streamlined approach that enables companies to realize long-term business benefits.
 
RIMS, or regulatory information management systems, allow life sciences companies to consolidate and analyze global regulatory information to support their submission planning, activity status, agency correspondence, and commitments for products. By combining machine learning with integration and automation, RIMS creates a single, digital regulatory thread. These solutions automate complex processes and provide predictive insights.
 
In addition to providing regulatory information, RIM systems also provide a full range of reporting, including custom dashboards, production registrations, standards, and documentation. These reports allow teams to monitor key information at a glance, as well as measure and benchmark their progress.
 
Regulatory affairs liaisons
 
The USFDA has issued guidance for the management of regulatory information related to a new drug application. This guidance covers a range of topics including the development and review of a drug application, the use of regulatory information, and the preparation of supporting studies and documentation.
 
Regulatory affairs is the process of working with the FDA to ensure that a new drug application or biological product meets the regulatory standards required for human use. This process is highly detail-oriented and requires good writing and communication skills.
 
The life sciences industry faces many challenges. Costs continue to rise, new markets are emerging, and regulatory bodies are increasing their demands. As a result, regulatory information management is becoming increasingly complex. The life sciences industry spends several billion dollars annually on managing its content and information.

Related Reading:
  1. Operational Excellence FAQ: Why should you modernize regulatory information management in life sciences organizations?
  2. Challenges in Modernizing Life Sciences Regulatory Information Management Systems 
  3. Economic Impact of Life Sciences Regulatory Information Management
  4. What are the drawbacks if Regulatory Information Management (RIM) of life sciences organizations is not modernized?
  5. Modernize regulatory information management to improve operational excellence in life science organizations 
  6. How to Overcome Challenges in Life Sciences Regulatory Information Management 
  7. Benefits of modernizing life sciences Regulatory Information Management
  8. Transitioning from Computer Software Validation (CSV) to Computer Software Assurance (CSA)​

Follow Shruti
 on 
Twitter, Facebook, YouTube, LinkedIn

Categories:  Life Sciences | Operational Excellence | Continuous Improvement

Keywords and Tags:
#CSAguidelines  #computersoftwareassurance #CSVguidelines #CSVtoCSA #lifesciences #continuousimprovement #operationalexcellence #continuousimprovementforlifescienceindustry #changemanagement #cGMP #cGLP #cGAMP #goodmanufacturingpractices #goodlaboratorypractices  #goodautomatedmanufacturingpractices #FDA
Get In Touch
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Shruti Bhat, global leader in business turnaround, operational excellence and continuous improvement

    New Book Released!

    top ten strategic decision-making tools for operational excellence

    Shruti's YouTube Channel ...

    Picture

    Blog Categories

    All
    3D Printing
    5S
    Agile
    Artificial Intelligence
    Automation
    Balanced Score Card
    Biotechnology
    Books
    Business Turnaround
    Case Studies
    Change Management
    Chemical Industry
    CMMI
    Continuous Improvement
    Design Thinking
    Digitalization
    Drug Delivery
    External News Links
    Food Industry
    Hall Of Fame
    Healthcare
    Hoshin Kanri
    HR Development
    Innovation
    ISO
    Just In Time
    Kaizen
    Leadership
    LEAN
    Lean Six Sigma
    Life Sciences
    Machine Learning
    Manufacturing
    Medical Devices
    Mistake Proofing
    Motivational Cards
    Nanotechnology
    Operations
    Packaging
    Patents
    Personal Products
    Process Improvement
    Product Development
    Productivity Increase
    QbD
    Quality Management
    Robotics
    Scrum
    Service Industry
    Six Sigma
    Strategy
    Supply Chain Logistics
    Telecom Industry
    TQM
    Videos
    Voice Of Customer
    Workshops

    Shruti's books...

    Picture
    shruti bhat, business process management, continuous improvement
    kaizen for pharmaceutcials, medical devices and biotech industry book by Dr Shruti Bhat
    Book on Continuous improvement tools by Dr Shruti Bhat
    kaizen for leaders, continuous process improvement tool to increase profit and organizational excellence by shruti bhat
    kaizen, shruti bhat, continuous improvement, quality, operations management
    Picture
    how to overcome challenges of creating effective teams
    how to lead a successful business transformation

    ​Micro-Learning
    ​Partner

    Picture

    Publishing Partner

    fast read books, business management books, health and wellness books, spiritual guidance books, best online book store

    Wellness
    ​Partner

    Picture
© Copyright 1992- 2022 Dr. Shruti Bhat ALL RIGHTS RESERVED.
See Terms and Conditions for details on this site usage.
SHRUTI BHAT, CONTACT
Click to connect.
Created by Macro2Micro Media